10/23/26: ESMO Congress Madrid - Eisai presents ROS1 insights ESMO 2026
11/02/26: First week of November, third quarter financial results
11/12/26: Society for NeuroOncology - 5 abstracts SNO Conference
01/11/27: J.P. Morgan Healthcare Conference J.P. Morgan Healthcare
Stocks can trade over-bought at certain levels and over-sold based on chart or valuation measures. Nuvation is currently trading oversold per chart. Some charts below from the close of trading on Friday the 2nd of October.
The daily chart has had a -29% pullback from a intermediate high of $7.26. RSI which is a relative strength index reading, is in extreme oversold territory at 29.11 per chart. Click to view.
This chart below illustrates how NUVB is trading against it's peers. I'm using the TEMA Oncology ETF symbol CANC as NUVB is one of 59 other oncology companies represented in that ETF. Companies must generate over 50% of their revenues from oncology to be held in the ETF. The CANC currently holds 425K shares of the company. Again, in very oversold condition against it's peers, with an RSI reading of 26.92.
Nuvation is a company working on unmet needs in oncology, and is for those who are willing to accept some risk in their portfolio, as a long term investors.
Disclaimer: This stock, or any other stock referenced on this site, is for educational purposes, not personalized advice. Consult with your investment advisor professional, prior to buying stocks, precious metals, commodity's, or crypto.
